Alysaa Co retweeted
âRemember Devin? It works now.â
After the internet said it wouldnât, Cognition put that on a billboard.
The @cognition story with @ScottWu46 and @aaref.
Alysaa Co retweeted
Three Swedish engineers with no legal experience started eating lunch every day with lawyers who didnât know much about AI.
@WeAreLegora went from that lunch table to $200M ARR.
A conversation with @MaxJunestrand and @merritthummer.
Alysaa Co retweeted
Today, China dominates rare-earth mining and processing.
But that wasnât always the case.
Solcoaâs @hoomanrenezhad explains how the West lost its rare-earth mojo:
"So contrary to popular belief, we do mine in the West. We have an enormous rare earth mine in Australia. Thereâs one in California."
âThe actual raw feedstock is not rare."
âThe bottleneck is what you do after it. Itâs the processing. That is something that weâre completely unable to do in the West."
âWe actually invented these processes in America."
"The technologies used to make rare earths in China today are American technologies from the Manhattan Project.â
âWe built this technology and these systems, and then we shipped it to China. China dominated. They matured it. They took over.â
Now his company is trying to bring that capability back to the U.S. with a process built for todayâs economics.
âIf we were just copying that same technology stack again, it was impossible. The economics donât close.â
Letâs make some metal!!
Rare earths are foundational to many of the worldâs most important technologies. Producing them end-to-end in the U.S. was considered impossible by some, until @hoomanrenezhad and Artem Iurkovskyi did it in a year with @solcoatech.
@alysaaco discusses their journey.
Alysaa Co retweeted
Today we're announcing $75M to build Solcoa One, our 500-tonne rare earth metallization plant in Nevada.
At Solcoa, we believe rare earths are the foundation of America's next great industrial era. An era we intend to win on the merits, with superior American technology.
I'm grateful for @hoomanrenezhad and Artem's leadership at this critical time. They bring the ability to fundamentally rethink a process while moving faster than many thought possible.
I'm honored to share that @BainCapVC is leading @solcoatech's $75M seed financing.
One year ago they were proving chemistry on a demo line, they've since scaled to a full production facility in Alameda, and today announce Solcoa One, their 500-tonne rare earth metallization plant in Nevada.
Alysaa Co retweeted
We @BainCapVC are leading the $25M seed financing in @corridorbrokers
SMBs have been sold the leftovers of the health insurance market for decades. Corridor gets them the best.
May the human remain the best interface. Honored to on board.
Bain Capital reaches every corner of the economy, from Proterial to athenahealth and Canada Goose. As techâs old boundaries disappear, its intersection with the real world has always been our domain.
Thrilled to announce BCVâs new $1.6B fund to back the founders using technology to transform the worldâs most important industries.
Make money. Have fun. Live with integrity. Everything else can change.
Fund XI. $1.6B total capital for those who know that it will.
Alysaa Co retweeted
In 1987, when Bain Capital was â3 years old, the early partners came up with the briefest possible mantra for running the firm: make money, have fun, live with integrity.
Excited that BCV has another $1.6B to do that. @kevinzhang , @ChristinaPhili5 , and I wrote a bit about those principles and the role that capital should play in a technological revolution:
baincapitalventures.com/insiâŚ
Make money. Have fun. Live with integrity. Everything else can change.
Fund XI. $1.6B total capital for those who know that it will.
Alysaa Co retweeted
AI labs figured out that curing cancer could be pretty good for the brand.
They might be right, but finding more molecules will only impact society if we change the long, expensive, and unpredictable process required to bring each one to market.
Our $150M Series C will help us scale the Forus network to change the economics of developing and launching new drugs. I shared more on @tbpn this week.